LM Advisors LLC Has $187,000 Stake in iShares Biotechnology ETF $IBB

LM Advisors LLC decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 83.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,109 shares of the financial services provider’s stock after selling 5,460 shares during the quarter. LM Advisors LLC’s holdings in iShares Biotechnology ETF were worth $187,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of IBB. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the 2nd quarter worth about $25,000. Basepoint Wealth LLC acquired a new stake in iShares Biotechnology ETF in the 4th quarter worth about $26,000. Cary Street Partners Financial LLC acquired a new stake in iShares Biotechnology ETF in the 4th quarter worth about $29,000. Copia Wealth Management acquired a new stake in iShares Biotechnology ETF in the 4th quarter worth about $34,000. Finally, Cornerstone Planning Group LLC acquired a new stake in iShares Biotechnology ETF in the 4th quarter worth about $35,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

Get iShares Biotechnology ETF alerts:

iShares Biotechnology ETF Price Performance

IBB stock opened at $170.66 on Friday. iShares Biotechnology ETF has a 12 month low of $123.61 and a 12 month high of $179.64. The company’s 50-day moving average price is $170.28 and its two-hundred day moving average price is $170.65.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were issued a $0.1218 dividend. This represents a $0.49 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Articles

• Five stocks we like better than iShares Biotechnology ETF
• Time to Sell? 3 Winners With Fading Technical Momentum
• Why These 2 Hotel Stocks Are Beating Travel Peers
• This Energy Stock Has Quietly Soared 130% in a Year
• 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.